Why Are Shares Of Xeris Biopharma Falling Friday?

Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev.Xeris Biopharma Holdings stock is taking a hit today. What’s weighing on XERS shares?Lawsuit Targets Two Pharmaceutical CompaniesThe lawsuit, filed by Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, targets unauthorized generic versions of Recorlev. The lawsuit names Torrent Pharmaceuticals Limited and Somerset Therapeutics, LLC as the ...